SJS Investment Consulting’s Oric Pharmaceuticals ORIC Stock Holding History

SJS Investment Consulting’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52K	Buy	+140	New	+$1.27K	﹤0.01%	1881

Other funds holding ORIC

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SJS Investment Consulting's ORIC Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 140 shares worth $1.52K. The stake represents ﹤0.01% of the portfolio and ranks #1881 among its holdings.

18 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

SJS Investment Consulting held 140 shares of Oric Pharmaceuticals worth $1.52K as of Q2 2026.
Oric Pharmaceuticals was a new SJS Investment Consulting position in Q2 2026.
Oric Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1881 holding.
18 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.